(Q33471712)

27 July 2017

title

Generation of tumour-necrosis-factor-alpha-specific affibody molecules capable of blocking receptor binding in vitro (English)

1 reference

27 July 2017

0 references

5

Fredrik Y Frejd

1 reference

27 July 2017

Andreas Jonsson

1

1 reference

27 July 2017

Helena Wållberg

series ordinal

2

1 reference

27 July 2017

Nina Herne

series ordinal

3

1 reference

27 July 2017

Stefan Ståhl

series ordinal

4

1 reference

27 July 2017

publication date

17 August 2009

1 reference

Biotechnology and Applied Biochemistry

27 July 2017

published in

1 reference

27 July 2017

volume

54

1 reference

27 July 2017

issue

2

1 reference

27 July 2017

page(s)

93-103

1 reference

Tumour necrosis factor antagonists: structure, function, and tuberculosis risks

27 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

New cytokine therapeutics for inflammatory bowel disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

A PEGylated Fab' fragment against tumor necrosis factor for the treatment of Crohn disease: exploring a new mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Comparisons of affinities, avidities, and complement activation of adalimumab, infliximab, and etanercept in binding to soluble and membrane tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Tumor necrosis factor antagonist mechanisms of action: a comprehensive review

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Bronchiolar inflammatory diseases: high-resolution CT findings with histologic correlation

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Radiolabeled compounds in diagnosis of infectious and inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Magnetic resonance imaging in early detection of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

PET imaging of acute and chronic inflammation in living mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Formatted anti-tumor necrosis factor alpha VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen-induced arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

A synthetic IgG-binding domain based on staphylococcal protein A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Alternative binding proteins: affibody binding proteins developed from a small three-helix bundle scaffold

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Tumor imaging using a picomolar affinity HER2 binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Directed evolution to low nanomolar affinity of a tumor-targeting epidermal growth factor receptor-binding affibody molecule

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

Selection and characterization of Affibody ligands binding to Alzheimer amyloid beta peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

A novel affinity protein selection system based on staphylococcal cell surface display and flow cytometry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FBA20090085

21 January 2018

Identifiers

DOI

10.1042/BA20090085

1 reference

27 July 2017

1 reference